bendroflumethiazide has been researched along with Demyelinating Diseases in 1 studies
Bendroflumethiazide: A thiazide diuretic with actions and uses similar to those of HYDROCHLOROTHIAZIDE. It has been used in the treatment of familial hyperkalemia, hypertension, edema, and urinary tract disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p810)
bendroflumethiazide : A sulfonamide consisting of 7-sulfamoyl-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide in which the hydrogen at position 6 is substituted by a trifluoromethyl group and that at position 3 is substituted by a benzyl group.
Demyelinating Diseases: Diseases characterized by loss or dysfunction of myelin in the central or peripheral nervous system.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cambier, J | 1 |
| Masson, M | 1 |
| Dairou, R | 1 |
| Gray, F | 1 |
| Henin, D | 1 |
| Laurent, D | 1 |
1 other study available for bendroflumethiazide and Demyelinating Diseases
| Article | Year |
|---|---|
[Centro-pontine myelinolysis associated with diffuse lesions of the white matter. Water-electrolyte disturbances associated with diuretic therapy].
Topics: Adult; Bendroflumethiazide; Brain Diseases; Demyelinating Diseases; Humans; Iatrogenic Disease; Male | 1977 |